Please join us in congratulating Amy Cheney, MD on her receival of the Society for Cardiovascular Angiography and Interventions, Women in Innovations (SCAI-WIN) Fellowship!
The $90,000 fellowship opportunity, provided by Abiomed and Boston Scientific, offers support to interventional cardiology fellows and practicing cardiologists interested in an additional year of advanced training. The training is set to focus on complex and high-risk interventional procedures (CHIP) and percutaneous acute mechanical circulatory support training.
Dr. Cheney, one of our very own interventional cardiology chief fellows here at the University of Washington, was chosen from a highly accomplished pool of fellows for her “demonstrated commitment to the treatment of patients with complex coronary disease, spirit of investigation, and [her] tremendous support and mentorship” states J. Dawn Abbott, MD, FSCAI, chair of SCAI-WIN. Abbott personally congratulated Dr. Cheney on the fellowship, “looking forward to following [Cheney’s] career” as she continues to grow with the University of Washington.
Making a mark at TCT 2019
Dr. Cheney had the chance to sit down with Dr. J. Dawn Abbott and Dr. C. Michael Gibson at TCT 2019 and talk about the SCAI WIN-CHIP Fellowship and her plans with it, as well as discuss the bright future for the community of women in interventional cardiology.
“I am extremely honored and humbled to be the recipient of this year’s SCAI-WIN CHIP fellowship.” said Cheney as she was awarded the fellowship.
“I am grateful to the SCAI-WIN committee, to Abiomed and Boston Scientific, and to my incredible mentors at the University of Washington for their support, enthusiasm, and commitment to my education and career. I am eager to grow in my skills as coronary operator during this exceptionally exciting time in interventional cardiology. There is an ever-growing population of patients in need of complex coronary intervention, and I look forward to providing improved access to care for these patients. I am also committed to promoting the essential mission of SCAI-WIN -- to inspire future generations of outstanding female interventionalists to join this field."
Cheney hopes the promotion of women in the field continues, recalling moments in the University of Washington Medicine’s cath lab in which whenever she expressed interest, she was put up to the table and got to participate in intervention. It was that trust in her mentorship where she found “giving opportunity is the single, most important thing” one can do. We are incredibly proud of Dr. Amy Cheney, and honored to have her push the field of interventional cardiology with us.